Helsinn Investment Fund


Principality of Monaco

Homepage

Helsinn Investment Fund

12.11.2018 10:05

AMAL Therapeutics finalises CHF 33 million Series B round

Please login or
register to use the
bookmark feature

By continuing to use this website you agree with our TERMS AND CONDITIONS